Thirty-five U.S. stocks with market caps above $10 billion are trading at fresh all-time highs as of July 24, 2026. The top 10 span mega-cap consumer technology, global and regional banking, biopharmaceutical dealmaking, aerospace & defense manufacturing, and freight rail—a cross-section pointing to bank earnings strength, defense backlog re-rating, and mega-cap pricing power as the market's current momentum drivers.
The top 10 tickers leading this cohort - $Apple(AAPL)$, $JPMorgan Chase(JPM)$, $AbbVie(ABBV)$, $Bank of America(BAC)$, $HSBC Holdings PLC(HSBC)$, $RTX Corp(RTX)$, $Banco Bilbao Vizcaya Argentaria SA(BBVA)$, $Howmet Aerospace Inc.(HWM)$, $General Dynamics Corp(GD)$, $CSX Corp(CSX)$
-
Bank earnings supercycle continues: JPM and BAC delivered blowout Q2 2026 results on July 14, with double-digit revenue growth fueled by trading and investment banking fees, while HSBC and BBVA showed similar strength in NII and Mexico-driven profit growth respectively. Capital markets activity remains the standout theme across global financials heading into the back half of 2026.
-
Defense and aerospace backlogs hit records: RTX, GD, and HWM are all riding historic order backlogs and raised full-year guidance, with RTX's backlog reaching $289 billion and GD's estimated contract value topping $188 billion. Rising global defense spending and a persistent commercial aerospace aftermarket boom are driving repeated price-target upgrades across the group.
-
Apple reclaims the world's most valuable company title: AAPL surpassed Nvidia in market cap on July 17 and is trading near all-time highs ahead of its July 30 earnings print, supported by pricing power that let it pass through memory-chip cost increases without denting demand.
-
Industrial and transport cyclicals turn a corner: CSX posted record quarterly revenue on July 22 as freight volumes and pricing improved, a signal that rail and broader industrial demand may be inflecting higher after a soft 2025.
-
Core Business: Consumer hardware (iPhone, Mac, iPad, wearables) combined with a high-margin Services segment spanning the App Store, iCloud, and subscriptions.
-
Latest Developments: On July 17, 2026, Apple reclaimed the title of world's most valuable public company, overtaking Nvidia. That same day, HSBC upgraded the stock from Hold to Buy, citing an "operational turning point." Apple had raised prices on MacBooks and iPads on June 25, 2026 to offset a global memory-chip shortage, and it also filed suit against OpenAI this month alleging trade-secret theft. Q3 fiscal 2026 results are due July 30, 2026 — Tim Cook's final quarterly report as CEO before the transition to Ternus.
-
Q2 Fiscal 2026 Financial Highlights (reported April 30, 2026): EPS of $2.01 beat the $1.94 estimate; revenue reached a March-quarter record of $111.2 billion versus $109.7 billion expected; gross margin came in at 49.3%; Greater China revenue grew 28% year-over-year.
-
Price Target Outlook: Citi analyst Asiya Merchant raised her target from $315 to $365 on July 13, 2026, maintaining Buy. HSBC analyst Nicolas Cote-Colisson raised his target from $260 to $366 on July 17, 2026, upgrading to Buy. JPMorgan's Samik Chatterjee lifted his target from $325 to $345 on July 7, 2026.
-
Core Business: The largest U.S. bank by assets, spanning consumer and community banking, commercial and investment banking, and asset and wealth management.
-
Latest Developments: JPMorgan reported Q2 2026 results on July 14, 2026, with the Commercial & Investment Bank posting a 27% revenue jump on strong equity underwriting and trading. Management also addressed a new G-SIB capital requirement rising to 5.2% by 2028, an approximately $20 billion hit to buyback capacity.
-
Q2 2026 Financial Highlights: EPS of $6.14 beat the $5.74 estimate; managed revenue of roughly $58 billion rose about 27% year-over-year; net income was $16.9 billion with ROTCE of 23%; Consumer & Community Banking revenue rose 8%.
-
Price Target Outlook: BofA analyst Ebrahim Poonawala raised his target from $362 to $408 ahead of earnings, reiterating Buy. Keefe, Bruyette & Woods analyst Christopher McGratty raised his target from $363 to $370, also Buy.
-
Core Business: Biopharmaceutical company built around the immunology franchise (Skyrizi, Rinvoq) along with neuroscience and oncology, diversifying beyond the legacy Humira business.
-
Latest Developments: On July 19, 2026, AbbVie agreed to acquire Apogee Therapeutics for approximately $10.9 billion — its largest deal since 2019 — targeting the anti-IL-13 antibody zumilokibart for inflammatory and respiratory disease, with closing expected in Q3 2026. The company also cut its Q2 2026 EPS guidance to $3.57–$3.61 (below the $3.77 consensus) on July 6, 2026, citing IPR&D and milestone expenses; Q2 results are due July 31, 2026.
-
Q1 2026 Financial Highlights: Adjusted EPS of $2.65 came in $0.07 above the guidance midpoint; total net revenues reached $15.0 billion, up 12.4% year-over-year, powered by continued Skyrizi and Rinvoq growth.
-
Price Target Outlook: Morgan Stanley raised its target from $270 to $278 on April 30, 2026, maintaining Overweight. DZ Bank upgraded the stock from Hold to Strong Buy the same day.
-
Core Business: Diversified U.S. bank spanning consumer banking, global wealth and investment management, global banking, and global markets/trading.
-
Latest Developments: Bank of America cleared the 2026 Federal Reserve stress test, clearing the way for further capital returns to shareholders.
-
Q2 2026 Financial Highlights (reported July 14, 2026): EPS of $1.21 beat the $1.13 estimate; revenue rose 15% year-over-year to $31.56 billion; net income climbed 27% to $9.1 billion; trading revenue rose 33% for a 17th straight quarter of growth, while investment banking fees jumped 50%.
-
Price Target Outlook: Wells Fargo analyst Mike Mayo raised his target from $67 to $69 on July 15, 2026, maintaining Overweight. Barclays analyst Jason Goldberg raised his target from $71 to $72 the same day.
-
Core Business: London-headquartered global bank with deep exposure to Asia, particularly Hong Kong, spanning retail banking, wealth management, and corporate and institutional banking.
-
Latest Developments: HSBC reported 1Q26 results on May 5, 2026, raising its full-year banking net interest income guidance to around $46 billion (from at least $45 billion previously) and approving a first interim dividend of $0.10 per share. Interim (1H) results are due August 4, 2026.
-
1Q 2026 Financial Highlights: EPS of $2.12 beat the roughly $2.00 estimate; operating expenses of $8.7 billion rose 8% year-over-year; the expected credit loss charge reflected a $0.4 billion fraud-related exposure alongside allowances tied to the Middle East conflict.
-
Price Target Outlook: RBC Capital raised its target on the London-listed shares from GBX 1,200 to GBX 1,275 on May 14, 2026, maintaining Sector Perform. JPMorgan upgraded the stock to Neutral and lifted its target from GBX 1,370 to GBX 1,380.
-
Core Business: Aerospace and defense conglomerate combining Collins Aerospace avionics and systems, Pratt & Whitney jet engines, and Raytheon missile and defense systems.
-
Latest Developments: RTX reported Q2 2026 results on July 23, 2026 and raised full-year guidance across sales, EPS, and free cash flow, citing a record backlog of $289 billion ($170 billion commercial, $119 billion defense). The company also agreed to sell its Blue Canyon Technologies unit for $620 million.
-
Q2 2026 Financial Highlights: Adjusted EPS of $1.89 beat the $1.66 estimate, up 21% year-over-year; sales rose 14% to $24.7 billion (16% organic); free cash flow reached $2.9 billion; full-year adjusted EPS guidance was raised to $7.10–$7.25 from $6.70–$6.90.
-
Price Target Outlook: RBC Capital raised its target from $230 to $250 on July 24, 2026, maintaining Outperform. Jefferies raised its target from $220 to $250, and Bank of America raised its target from $230 to $235.
-
Core Business: Spanish banking group with major operations in Mexico, Turkey, and South America alongside its home retail and corporate banking business.
-
Latest Developments: BBVA is nearing completion of the third tranche of an extraordinary share buyback program worth up to €1.46 billion, bringing total repurchases since December to nearly €4 billion. Q2 2026 results are due July 30, 2026.
-
Q1 2026 Financial Highlights: Net profit rose approximately 11% year-over-year, driven primarily by strong performance in Mexico.
-
Price Target Outlook: JPMorgan raised its target from €23.40 to €23.70 on July 24, 2026, maintaining Buy. Bank of America downgraded the stock to Neutral from Buy on July 15, 2026.
-
Core Business: Engineered components supplier for aerospace, defense, and industrial gas turbines, including jet engine parts, fastening systems, and forged aluminum wheels.
-
Latest Developments: Howmet is set to report Q2 2026 results on August 6, 2026, with analyst price targets continuing to climb into the print on sustained aerospace supercycle demand.
-
Q1 2026 Financial Highlights (reported May 7, 2026): Adjusted EPS of $1.22 beat the $1.11 estimate; revenue rose 19% year-over-year to $2.31 billion; adjusted EBITDA rose 32% to $740 million with margin expanding 320 basis points to 32%; free cash flow more than doubled to $359 million; full-year guidance was raised to EPS of $4.88–$5.00.
-
Price Target Outlook: Jefferies raised its target from $320 to $340, maintaining Buy. Morgan Stanley raised its target from $280 to $315, maintaining Overweight, and Citi raised its target from $303 to $311.
-
Core Business: Diversified defense and aerospace company spanning Gulfstream business jets, Marine Systems (submarines), Combat Systems, and Technologies.
-
Latest Developments: General Dynamics is due to report Q2 2026 results on July 29, 2026. Its Land Systems division recently received a $209 million contract modification for the Abrams Engineering program, and shares hit a fresh 52-week high in July on broad defense-sector enthusiasm.
-
Q1 2026 Financial Highlights (reported April 29, 2026): EPS of $4.10 beat the $3.67 estimate; sales reached $13.48 billion; the company raised full-year EPS guidance to $16.45–$16.55 on $26.6 billion of new orders and a total backlog of $130.8 billion.
-
Price Target Outlook: Jefferies upgraded the stock from Hold to Buy and raised its target from $400 to $440, citing strength in the marine systems segment. Morgan Stanley raised its target to $435, and Bank of America maintains a $415 target, both with bullish ratings.
-
Core Business: Class I freight railroad operating across the eastern United States, moving merchandise, intermodal, and coal traffic.
-
Latest Developments: CSX reported record Q2 2026 revenue on July 22, 2026 and raised its full-year outlook on stronger intermodal demand, pricing gains, and cost discipline, sending shares to fresh 52-week highs.
-
Q2 2026 Financial Highlights: EPS of $0.54 beat the $0.52 estimate; revenue rose 10% year-over-year to a record $3.94 billion; net earnings reached $1.00 billion; operating margin expanded 240 basis points to 38.3% on 6% volume growth.
-
Price Target Outlook: Citigroup raised its target from $53 to $54 on July 25, 2026, maintaining a Neutral rating; JPMorgan, Bank of America, TD Cowen, and UBS also raised targets or reaffirmed bullish ratings following the print.
Comments